vision will improve
dramatically after sur-
gery — and delivering
on that promise —
remains cataract
surgery's foundation
for success. Nearly all
of our survey's respon-
dents say multifocal
IOLs (87%) and toric
IOLs (94%) let sur-
geons achieve precise post-op visual results.
Ms. Cappella says a new IOL that promises excellent distance and
intermediate vision and functional near vision has caught the eye of
her surgeons, so she's had to adjust the lenses she keeps on consign-
ment to ensure they have access to their preferred implants.
Managing her lens inventory is no easy task. She tries to get surgeons
to agree on a single lens, but often ends up with a closet packed with
options.
• Lens loading. Preloaded IOL-injection systems are used in only
38% of facilities, our survey found. That's somewhat surprising,
considering the reported benefits they provide. Ms. Cappella says
her surgical techs have to learn how to load various IOLs into vari-
ous injectors. It's a difficult process that can result in torn lenses,
wasted time and frustrated surgeons. "It's a skill you have to devel-
op and practice," says Ms. Cappella. "Preloaded IOL-injector sys-
tems eliminate a lot of stress from the techs' perspective."
• Surgeon satisfiers. The bad news: Ophthalmic surgeons who sit
awkwardly for hours on end performing the same procedure over
and over again are susceptible to debilitating neck and back strains.
A U G U S T 2 0 1 7 • O U T PA T I E N TS U R G E R Y. N E T • 7 7
• SEEING IS BELIEVING Facility leaders pointed to premium IOLs as the primary
technology that lets surgeons deliver on promises of excellent refractive outcomes.
Pamela
Bevelhymer,
RN,
BSN,
CNOR
